Lonza adds biologics capacity with $1.2bn Roche deal

Lonza adds biologics capacity with $1.2bn Roche deal

Submitted by admin on March 20, 2024 - 11:17am
Source: 
Pharmaphorum
News Tags: 
Roche
Lonza
drug manufacturing
Switzerland
CDMOs
Headline: 
Lonza adds biologics capacity with $1.2bn Roche deal
snippet: 

Roche is set to raise $1.2 billion from the sale of a US biologics manufacturing facility to Swiss contract development and manufacturing organisation (CDMO) Lonza, part of a drive to match capacity with pipeline requirements.

Do Not Allow Advertisers to Use My Personal information